# OnCo record mosun-lbt-fl (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/mosun-lbt-fl/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "mosun-lbt-fl", "NCT06337318" ;
  schema:name "Mosunetuzumab against rituximab in low tumour burden follicular lymphoma"@en ;
  schema:alternateName "Rituximab versus mosunetuzumab in low tumour burden follicular lymphoma"@en ;
  schema:description "A large American trial testing whether a two-headed antibody that recruits the immune system should replace the standard antibody as the first treatment for slow-growing follicular lymphoma."@en ;
  schema:url <https://onco.cc/trials/mosun-lbt-fl/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06337318> ;
  onco:status "active" ;
  onco:tag "lymphoma-evidence" ;
  onco:phase "3" ;
  schema:startDate "2024-10-23" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cd20/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/rituximab/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/flipi/>, <https://onco.cc/terms/watchful-waiting/>, <https://onco.cc/terms/lymphoma-tx-watch-and-wait/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-drug-pricing/> .